HLA-E Presents Glycopeptides from the Mtb Protein MPT32 to Human CD8 T Cells

ABSTRACT: Infection with Mycobacterium tuberculosis (Mtb), the bacterium that causes Tuberculosis, remains a global health concern. Both classically and non-classically restricted cytotoxic CD8+ T cells are important to the control of Mtb infection. We and others have demonstrated that the non-classical MHC I molecule HLA-E can present pathogen-derived peptides to CD8+ T cells. In this manuscript, we identified the antigen recognized by an HLA-E-restricted CD8+ T cell clone isolated from an Mtb latently infected individual as a peptide from the Mtb protein, MPT32. Recognition by the CD8+ T cell clone required N-terminal O-linked mannosylation of MPT32 by a mannosyltransferase encoded by the Rv1002c gene. This is the first description of a post-translationally modified Mtb-derived protein antigen presented in the context of an HLA-E specific CD8+ T cell immune response. The identification of an immune response that targets a unique mycobacterial modification is novel and has practical impact in the development of vaccines and diagnostics.

INSTRUMENT(S): LTQ Orbitrap, LTQ

ORGANISM(S): Mycobacterium Tuberculosis

TISSUE(S): Prokaryotic Cell

DISEASE(S): Tuberculosis

SUBMITTER: Lisa Wolfe  

LAB HEAD: Karen Marie Dobos

PROVIDER: PXD005765 | Pride | 2018-10-26

REPOSITORIES: Pride